期刊文献+

某院28080张门急诊处方用药点评与不合理处方的原因分析及其对策 被引量:1

Analysis on Medication Comment and Unreasonable Reasons of 28080 Prescriptions of Out-patient and Emergency in a Hospital and Their Countermeasures
下载PDF
导出
摘要 目的:分析医院门急诊不合理处方用药原因与对策,为合理用药提供参考。方法:抽取医院2020年1月—9月门急诊处方28 080张,依据药品说明书和相关法规等要求,点评与分析其用药的合理性,对不合理处方的原因提出管理对策。结果:28 080张处方中,不合理处方1 333张,处方不合理率为4.75%;在不合理处方中,其不合理原因1 406例次;其含抗菌药物处方261张(占19.58%),含中成药处方379张(占28.43%),处方平均药品数为(2.83±1.97)种;不合理处方TOP 5的科室为普通内科(18.90%)、皮肤科(9.83%)、眼科(8.10%)、耳鼻咽喉科(7.88%)和妇科(5.48%);不合理处方主要类型有:处方未写明"临床诊断"或临床诊断书写不全的413例次(占29.37%);用法、用量不适宜的206例次(占14.65%);适应证不适宜的192例次(占13.66%);联合用药不适宜的151例次(占10.74%);用法、用量含糊不清的114例次(占8.11%);医师未按照《抗菌药物临床应用指导原则》中管理规定,开具抗菌药物处方的88例次(占6.26%)。结论:医院处方质量总体较好,不合理的突出问题有待改进,应定期开展处方用药合理性点评,以确保患者用药的安全性和有效性。 Objective: To analyze the causes of unreasonable reasons drug usage in outpatient and emergency departments and their countermeasures, and to provide reference for rational drug usage. Methods: A total of 28 080 prescriptions of outpatient and emergency were selected from the hospital from January to September 2020. According to the drug instructions and relevant regulations, the rationality of drug use was evaluated and analyzed, and management countermeasures were put forward for the causes of unreasonable prescriptions. Results: In 28 080 prescriptions, 1 333 prescriptions were unreasonable, and the rate of irrational prescriptions was 4.75%. Among the unreasonable prescriptions, there were 1 406 cases of unreasonable reasons. There were 261 prescriptions containing antibacterials(19.58%),379 prescriptions containing Chinese patent medicine(28.43%), and the average number of drugs was(2.83±1.97) kinds.The TOP 5 departments with unreasonable prescriptions were general internal medicine(18.90%), dermatology(9.83%),ophthalmology(8.10%), otolaryngology(7.88%) and gynecology(5.48%). The main types of unreasonable prescriptions were as follows: 413 cases did not specify "clinical diagnosis" or incomplete clinical diagnosis, accounting for 29.37%;206 cases of improper usage and dosage accounted for 14.65%. The proportion of unsuitable indications was 13.66% in192 cases.151 cases(10.74%) were unsuitable for combined drug usage. The usage and dosage were unclear in 114 cases(8.11%). Physicians did not comply with the management provisions in the "Guiding Principles for Clinical Application of Antibacterials", and 88 cases of antibacterials prescriptions were issued, accounting for 6.26%. Conclusions: The overall quality of hospital prescriptions is good, but the prominent unreasonable problems need to be improved. The regular evaluation on the rationality of prescription medication should be carried out to ensure the safety and effectiveness of medication for patients.
作者 汤晨 张桂芬 王建 魏菊红 朱爱国 TANG Chen;ZHANG Gui-fen;WANG Jian;WEI Ju-hong;ZHU Ai-guo(Changshu No.1 People's Hospital,Changshu Jiangsu 215500,China;Changshu Hospital Affiliated to Soochow University,Changshu Jiangsu 215500,China)
出处 《抗感染药学》 2021年第7期966-972,共7页 Anti-infection Pharmacy
关键词 处方点评 不合理处方 管理对策 合理用药 prescription comment Irrational prescription management countermeasures rational drug usage
  • 相关文献

参考文献7

二级参考文献60

  • 1张晋红,章国英.贝那普利与缬沙坦双重阻断肾素-血管紧张素系统对老年糖尿病肾病疗效的影响[J].中国老年学杂志,2014,34(4):890-891. 被引量:13
  • 2李洋,颜虹.处方信息的分析和利用[J].中国医院统计,2005,12(1):79-82. 被引量:228
  • 3王若琦.血管紧张素转换酶抑制剂与血管紧张素Ⅱ受体拮抗剂联用治疗慢性心力衰竭的研究进展[J].心脏杂志,2007,19(1):102-103. 被引量:4
  • 4Steinhubl SR. Genotyping, clopidogrel metabolism, and the search for the therapeutic window of thienopyridines [J]. Circulation, 2010,121(4) :481. 被引量:1
  • 5Varenhorst C, James S, Erlinge D, et al. Genetic variation of CYP2C19 affects both pharmacokinetic and pharmacodynamic responses to clopidogrcl but not prasugrel in aspirin-treated patients with coronary artery disease[J]. Eur Heart J, 2009,30(14) :1744. 被引量:1
  • 6Shu Y, Zhou HH. Individual and ethnic differences in CYP2C19 activity in Chinese populations [ J ]. Acta Pharmacol Sin, 2000,21 ( 3 ) : 193. 被引量:1
  • 7Sire SC, Risinger C, Dahl ML, et al. A common novel CYP2C19 gene variant causes ultrarapid drug metabolism relevant for the drug response to proton pump inhibitors and antidepressants [ J]. Clin Pharmacol Ther, 2006 ,79 (1) :103. 被引量:1
  • 8Sibbing D, Koch W, Gebhard D, et al. Cytochrome 2C19 * 17 allelic variant, platelet aggregation, bleeding events, and stent thrombosis in clopidogrel-treated patients with coronary stent placement[ J1. Circulation, 2010,121 (4) :512. 被引量:1
  • 9Baldwin RM, Ohlsson S, Pedersen RS, et al. Increased omeprazole metabolism in carriers of the CYP2C19 * 17 allele; a pharmacokinetic study in healthy volunteers[ J]. Br J Clin Pharmacol, 2008,65 (5) :767. 被引量:1
  • 10FDA. Announces New Boxed Warning on Plavix Alerts patients, health care professionals to potential for reduced effectiveness [ N ]. http://www, fda. gov/NewsEvents/ Newsroom/PressAnnouncements/ucm204253. htm. 被引量:1

共引文献37

同被引文献17

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部